Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 2,498 | 156 | 4,131 | 1,517 | 268 |
| Gross Profit | 2,498 | 156 | 4,131 | 1,517 | 268 |
| Operating Expenses | 48,815 | 40,764 | 51,758 | 42,756 | 33,473 |
| Operating Income | -46,317 | -40,608 | -47,627 | -41,239 | -33,205 |
| Other Income | 10,475 | 7,800 | 4,321 | 2,979 | 2,703 |
| Pre-tax Income | -35,842 | -32,808 | -43,306 | -38,260 | -30,502 |
| Net Income Continuous | -35,842 | -32,808 | -43,306 | -38,260 | -30,502 |
| Net Income | $-35,842 | $-32,808 | $-43,306 | $-38,260 | $-30,502 |
| EPS Basic Total Ops | -0.54 | -0.56 | -0.84 | -0.81 | -0.65 |
| EPS Basic Continuous Ops | -0.54 | -0.56 | -0.84 | -0.81 | -0.65 |
| EPS Diluted Total Ops | -0.54 | -0.56 | -0.84 | -0.81 | -0.65 |
| EPS Diluted Continuous Ops | -0.54 | -0.56 | -0.84 | -0.81 | -0.65 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.56 | -0.57 | N/A | N/A |
| EBITDA(a) | $-50,260 | $-43,146 | $-49,047 | $-42,099 | $-33,609 |